dasabuvir
Jump to navigation
Jump to search
Indications
* including patients with cirrhosis
Dosage
- one tablet twice a day
- used in combination with ombitasvir/paritaprevir/ritonavir (Viekira Pak)
Mechanism of action
- non-nucleoside RNA polymerase inhibitor
More general terms
Component of
References
- ↑ Orciari Herman A and Sofair A Viekira Pak Approved for Hepatitis C Physician's First Watch, Dec 22, 2014 David G. Fairchild, MD, MPH, Editor-in-Chief Massachusetts Medical Society http://www.jwatch.org
FDA News Release. Dec 19, 2014 FDA approves Viekira Pak to treat hepatitis C http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427530.htm